3658 results for «391»
3658 results
How to treat aortic regurgitation
22 May 2026 – From EuroPCR 2026
Explore cutting-edge transcatheter approaches for aortic regurgitation, including first-in-human ATLAS technique, management in LVAD patients, and off-label Myval use. This session reviews clinical challenges and innovative solutions in aortic valve interventions, offering valuable insights from complex procedural experiences.
Left main PCI: predictions of risk and long-term clinical outcome
22 May 2026 – From EuroPCR 2026
This session focuses on risk prediction and long-term outcomes following left main percutaneous coronary intervention (PCI). It covers biomarkers like NT-proBNP, hemodynamic predictors, and the impact of comorbidities such as diabetes and chronic kidney disease on patient prognosis over a ten-year follow-up.
Right-sided interventions and impact on the right heart
22 May 2026 – From EuroPCR 2026
This session examines right-sided cardiac interventions and their impact on right heart function. Topics include prognostic implications of right ventricular wall tension, novel metrics for RV-PA coupling, clinical effects of severe tricuspid regurgitation, and strategies for transcatheter pulmonary valve replacement in complex right ventricular outflow tract...
Technical decision-making for CTO PCI strategy
22 May 2026 – From EuroPCR 2026
This session focuses on technical decision-making for chronic total occlusion PCI strategy. It presents diverse approaches to right coronary CTOs, complex management involving double rendezvous techniques, subintimal strategies, and innovative single-injection methods, demonstrating the evolving frontiers in CTO intervention.
Updates in tricuspid TEER
21 May 2026 – From EuroPCR 2026
This session offers comprehensive updates on transcatheter edge-to-edge repair (TEER) for tricuspid valve disease. It reviews meta-analyses on outcomes in patients with cardiac implantable electronic device leads, long-term trial results, echocardiographic and clinical outcomes, right ventricular mechanics, risk scoring, and the impact of renal function and...
Best structural complications
22 May 2026 – From EuroPCR 2026
This session highlights the management of complex structural complications encountered in high-risk valve interventions. It covers troubleshooting in mitral annular calcification, challenges with the BASILICA technique, creative bailouts for valve embolisation, and considerations in leaflet management during aortic stenosis procedures.
Challenging PCI on bifurcation lesions
22 May 2026 – From EuroPCR 2026
Addressing the complexities of PCI in bifurcation lesions, this session highlights novel techniques such as the TAP and modified mini-crush methods, alongside strategies for managing challenging coronary anatomy. Validation of novel approaches like POT-side DCB-POT for left main bifurcations is also featured.
Unusual clinical cases: thinking beyond the routine
22 May 2026 – From EuroPCR 2026
This session presents unusual and challenging clinical cases that extend beyond routine interventional cardiology. From optimised in-stent restenosis treatment to rare anatomical anomalies and complex thrombus management, it offers valuable lessons in creative problem-solving and advanced intervention techniques.
LAA closure and pulmonary embolism hotline
22 May 2026 – From EuroPCR 2026
Focusing on left atrial appendage (LAA) closure and pulmonary embolism management, this session reviews device-related thrombus, implant healing with novel coatings, and compares mechanical thrombectomy to catheter-directed thrombolysis. It also discusses the prognostic impact of hemodynamic data post-thrombectomy to inform clinical outcomes.
Taking on the tough stuff: TAVI in complex anatomies
21 May 2026 – From EuroPCR 2026
Focused on the challenges of transcatheter aortic valve implantation (TAVI) in complex anatomies, this session addresses optimal strategies for treating bicuspid aortic valve stenosis, managing small annuli and low coronary ostia, and approaches to degenerated surgical valves including bioprosthetic fracture techniques. Case-based discussions elucidate practical solutions...
Management of uncommon TAVI complications
21 May 2026 – From EuroPCR 2026
This session delves into the management of uncommon but critical complications arising from Transcatheter Aortic Valve Implantation (TAVI). Through detailed case studies from Italy, Lebanon, and Turkey, it highlights real-time decision-making strategies for life-threatening scenarios including left ventricular outflow tract obstruction, acute aortic dissection, and complex...
DCB: what we know and what we do not know
22 May 2026 – From EuroPCR 2026
This session provides a detailed update on drug-coated balloons (DCB) in interventional cardiology, covering the latest clinical data and trials. It identifies scenarios where DCB use is most effective and offers guidance on optimizing procedural techniques to enhance clinical outcomes.
Spectrum of cardiogenic shock
21 May 2026 – From EuroPCR 2026
This session delves into the broad spectrum of cardiogenic shock phenotypes, emphasizing the importance of selecting appropriate left ventricular support tailored to specific clinical scenarios. It offers critical insights into the timing of mechanical circulatory support and revascularisation strategies to optimize patient outcomes.
Challenging cases in calcified lesions PCI
22 May 2026 – From EuroPCR 2026
This session addresses challenging cases in PCI of heavily calcified lesions. It covers unexpected complications such as silent shockwave failures, interventions in calcified Kawasaki disease, delayed coronary obstructions post-TAVI, and complex left main bifurcation lesions. The session underscores the perseverance required to successfully navigate these demanding...
When anatomy surprises: closing rare fistulae
21 May 2026 – From EuroPCR 2026
This session focuses on the percutaneous closure of rare and complex cardiac fistulae and related vascular anomalies. It presents diverse cases such as superior vena cava syndrome from pacemaker leads, iatrogenic aorta-to-left atrium fistula, and unusual cardio-pulmonary connections, illustrating advanced interventional techniques to address unexpected anatomical...
Controversies and conversations in TAVI
21 May 2026 – From EuroPCR 2026
This session addresses key controversies and discussions in transcatheter aortic valve implantation (TAVI), including the role of invasive coronary angiography prior to TAVI, use of cangrelor during combined TAVI and high-risk PCI, and discrepancies in aortic valve stenosis assessment methods. Additional topics cover operator models, valve...
Diagnosis and management of INOCA and ANOCA
21 May 2026 – From EuroPCR 2026
This session focuses on the diagnosis and management of ischemia and angina with non-obstructive coronary arteries (INOCA and ANOCA). It presents safety data from coronary function testing, patient outcomes after comprehensive ischemia assessment, and endotype-specific treatment effects. Further topics include coronary sinus reducer therapy, the impact...
Calcified lesion of distal protected left main - LIVE case
22 May 2026 – From EuroPCR 2026
An 85‑year‑old man with type 2 diabetes mellitus, hypertension, dyslipidemia, peripheral artery disease, COPD, and chronic kidney disease presented with CCS class II angina related to three‑vessel coronary artery disease. He had previously undergone hybrid revascularization, including PCI of the RCA ostium and CABG with LIMA...
Assessing coronaries in ACS with intracoronary imaging
21 May 2026 – From EuroPCR 2026
This session highlights the critical role of intracoronary imaging in evaluating acute coronary syndromes (ACS). It discusses the management of complex lesion morphologies involving calcium and thrombus, the diagnostic power of OCT in decision-making, challenges beyond angiography in right coronary artery pathology, and the identification of...
Challenges of multivessel disease in ACS
21 May 2026 – From EuroPCR 2026
Dedicated to the challenges of multivessel disease in acute coronary syndrome (ACS), this session explores strategies to identify culprit versus non-culprit lesions and plan multivessel revascularisation using physiology, intravascular imaging, and artificial intelligence. It further discusses the timing considerations for revascularisation, whether ad-hoc or staged, illustrated...
